About Us
The Management Team
The GeneticHealth clinic located in Harley Street is a state of the art diagnostic centre. Here you can meet our expert doctors in the field of genetics and anti-ageing.
The GeneticHealth’s team are committed to bring the highest standards of genetic diagnostic testing to you. All our therapies and advice are built around evidence based medicine. We only rely on and refer to data that has been published in peer reviewed medical and scientific research articles.
We firmly believe in clinical excellence and strive to continually improve our work by constant reference to studies around the world and original research carried out by our own team and our European partners.
Brian Whitley BSc, MSc., Managing Director
 Brian Whitley has been involved in healthy ageing for over 10 years. He has extensive experience in running medical companies since late 1980’s when he became managing director of the medical instrument company GU manufacturing. Prior to this he was Technical Director of Downs surgical (now part of Aesculap) and held various marketing Director positions in UK medical companies.
His main interest now is developing evidence-based therapies for disease prevention.
back to top
Dr Paul Jenkins MA BChir MD FRCP
 Reader in Endocrine Oncology, Honorary Consultant Physician, St Bartholomew’s Hospital, Queen Mary School of Medicine and Dentistry, University of London. He is Medical Advisor of the European Scanning Centre which is one of only two centres in the UK to use an Electron Beam CT (EBCT) scanner. Paul is a specialist in endocrinology (hormones), particularly growth disorders, and is a leading researcher into how hormones influence our predisposition to a number of cancers, especially cancer of the colon. He leads an active research team and has published over 60 research papers in the field of hormones and genetic actions in the human body. In addition he has written numerous chapters for textbooks, and is regularly invited to present his work at national and international meetings. He has a special interest in the role of genetics in disease prevention and ageing.
back to top
Dr Lynette Yong MA, MBBS, FRCS, LF Hom.
 Dr Lynette Yong studied medicine at Cambridge University and
at St Mary's Hospital in London. She completed her surgical
fellowship in London with the Royal College of Surgeons of
England. She has a special interest in the application of
genetic analysis to the prescribing of hormones for men and women.
back to top
Nicola Panton
 Nicola Panton is key member of the GeneticHealth team of laboratory scientists. She obtained her BSc in Molecular and Cellular Biology from one of the leading universities in South Africa, the University of Stellenbosch in 2004. She continued her studies at the University of Stellenbosch and was awarded her Honours cum laude in Genetics in 2005 and was placed as the top BSc Honours student of that year. She has recently obtained her MSc in Genetics. She has a keen interest in genetic analysis and how this may aid in the prevention and/or awareness of common diseases.
back to top
The Medical Advisory Board
Dr David Brull
Dr Brull qualified from the Royal Free Hospital Medical School in 1992 and has since worked in several London teaching hospitals (Guys Hospital, The Royal Free and University College London Hospitals) before being appointed as Consultant Cardiologist and Honorary Senior Lecturer to The Whittington Hospital and The Heart Hospital, UCLH in October 2003. His main clinical interests are in coronary intervention (angioplasty and stenting) and the genetics of cardiovascular disease. He has an MD thesis from the Cardiovascular Genetics Department at University College, London and has published a number of scientific research papers primarily focusing on aspects of gene-environment interaction in cardiovascular disease and the genetics of the inflammatory response.
back to top
Dr Mel Lobo
Dr Lobo qualified in medicine from the University of Manchester in 1989 and was appointed as Consultant Physician in Cardiovascular Medicine and Clinical Pharmacology at St Bartholomew’s & The London NHS Trust in 2002. He was awarded a PhD in Cell Biology in 2000 from the University of London. Dr Lobo has specialist interests in cardiovascular risk factor modification and the influence of genetic mechanisms on this. He is an honorary Senior Lecturer in the William Harvey Research Institute and has an academic interest in the field of pharmacogenomics. He is a member of the Trust New Drugs Group and Medicine Safety Group.
back to top
The Scientific Advisory Board
Professor Stephen Bustin BA PhD
Professor of Molecular Medicine, Institute of Cell and Molecular Science, Queen Mary University of London. Stephen is a leading researcher in the genetic determinants of colonic cancer, and heads a large and productive research team, with more than 70 research papers to his name. He is one of the most highly regarded international figures in PCR gene analysis, and has written what is generally regarded as the definitive textbook in this area. He organises meetings throughout the world for researchers in this field, and is at the very forefront of new developments in genetic analysis.
back to top
Dr Roberto Motterlini
Honorary Senior Lecturer, at University College London and Head of the Vascular Biology Unit at Northwick Park Institute for Medical Research. Dr. Motterlini (PhD) is a fellow of the American Heart Association and currently leads a research team investigating the functional role of the cytoprotective enzyme heme oxygenase and its products (carbon monoxide and bilirubin) in the mitigation of cardiovascular dysfunction. He also has a strong interest in the therapeutic effects of natural compounds as activators of defensive cellular systems and has published over 90 scientific articles. As an advisor to GeneticHealth Ltd, Dr. Motterlini will be assisting in the scientific development of a range of unique and powerful antioxidants to combat the effects of free radical and toxic damage in the body.
back to top
Dr Roberta Foresti
Dr. Foresti (PhD) is currently a Senior Research Scientist at Northwick Park Institute for Medical Research and Honorary Lecturer at University College London. She obtained her degree at the University of Milan and completed her doctoral thesis at the University of California San Diego.
She has recently completed a Masters Degree in Human Nutrition at King’s College London. Dr. Foresti has published over 50 research papers and has a special interest in human nutrition and nutrigenomics. She is working with our team to examine how different foods may interact with specific genes to increase the risk of common chronic diseases such as type 2 diabetes, obesity, heart disease, stroke and certain cancers. GeneticHealth Ltd’s nutrigenomics research program seeks to validate the theory that common chemicals in diet can affect health by altering the expression of genes.
back to top
|
